Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.80 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.80 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.80 |
| ▸ | DRD2 | P14416 | 2/20 | 0.55 |
| ▸ | DRD3 | P35462 | 2/20 | 0.55 |
| ▸ | MAOA | P21397 | 2/20 | 0.50 |
| ▸ | MAOB | P27338 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.43 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Homopterocarpin SCHEMBL31237481 | 1.00 | MAPT (0.80) | MAPTMAPK1TDP1DRD2DRD3 | |
| Homopterocarpin SCHEMBL12998414 | 1.00 | MAPT (0.80) | MAPTMAPK1TDP1DRD2DRD3 | |
| Homopterocarpin SCHEMBL12810803 | 1.00 | MAPT (0.80) | MAPTMAPK1TDP1DRD2DRD3 | |
| Homopterocarpin SCHEMBL29366996 | 1.00 | MAPT (0.80) | MAPTMAPK1TDP1DRD2DRD3 | |
| SCHEMBL18602053 | 0.93 | MAPT (0.71) | MAPTMAPK1TDP1DRD2DRD3 | |
| SCHEMBL12891389 | 0.93 | MAPT (0.71) | MAPTMAPK1TDP1DRD2DRD3 | |
| SCHEMBL12810063 | 0.93 | MAPT (0.70) | MAPTMAPK1TDP1DRD2DRD3 | |
| SCHEMBL19999732 | 0.92 | MAPT (0.70) | MAPTMAPK1TDP1DRD2DRD3 | |
| SCHEMBL12912390 | 0.92 | MAPT (0.70) | MAPTMAPK1TDP1DRD2DRD3 | |
| SCHEMBL72476 | 0.92 | MAPT (0.70) | MAPTMAPK1TDP1DRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | YewSavin, Inc. (US) | 2025-07-01 | — | — | US | disclosed |
| WO-2024233598-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2024-11-14 | — | — | WO | disclosed |
| EP-4429763-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | Yewsavin, Inc. (US) | 2024-09-18 | — | — | EP | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
| US-20230040081-A1 | VACCINIA VIRAL POLYMERASE-MEDIATED VIRAL REPLICATION | IMMUNOLUX INTERNATIONAL CORP. | 2023-02-09 | — | — | US | disclosed |
| US-8633203-B2 | Use of pterocarpans as active anti-cellulite ingredients | SYMRISE AG (DE) | 2014-01-21 | — | — | US | disclosed |
| EP-2295031-A2 | Use of pterocarpans as anti-cellulite agents | Symrise AG (DE) | 2011-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | MAPT 3297/4885MAPK1 3352/4885TDP1 3071/4885 |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | SERPINC1, SERPINE1, SERPINH1 | MAPT 3512/4885MAPK1 3412/4885TDP1 3151/4885 |
| US-20230040081-A1 | VACCINIA VIRAL POLYMERASE-MEDIATED VIRAL REPLICATION | POLR1G, POLR1A, POLR1E | MAPT 3581/4885MAPK1 3815/4885TDP1 232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.